secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scilex Holding Co (SCLX)
CIK:        0001820190
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001193125-26-205839
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scilex subsidiary to sell ACEA Pharma to Phoenix Asia for $1B in stock, owning 82% post-close
--------------------------------------------------------------------------------

- ACEA Thera sells 100% of ACEA Pharma to Phoenix Asia for 100M shares at $10/share, valued at $1B.
- Post-close, ACEA Thera will own ~82% of Phoenix; Phoenix will be renamed ACEA Pharma.
- Boards of all parties unanimously approved; deal expected to close by end of Q2 2026.
- Closing conditions include HSR clearance, Nasdaq approval, and no material adverse effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1820190/000119312526205839/0001193125-26-205839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1820190/000119312526205839/sclx-20260504.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-205839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer